Lin Chen: Clinical Trials

1 trial sponsored by Lin Chen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Lin Chen: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Esmolol in Sepsis Management:Evaluating Immunomodulatory Effects and Impact on Patient Outcomes
esmolol - Sepsis, Lymphocyte Disorder T
Phase 2CompletedLin Chen1502021-01-012024-05-29

Conditions studied

Autonomic Nervous System Diseases (1)  ·  Cytokine Release Syndrome (1)  ·  Sepsis (1)

Interventions

esmolol (1)

Countries

China (1)

Results publications

PMID 38240494, PMID 40421209